Voglibose API

Xi'an Faithful BioTech Co., Ltd: Your Trusted Voglibose API  Manufacturer & Supplier

Xi'an Faithful BioTech Co., Ltd provides high-quality Voglibose API. We are an enterprise that integrates production and sales. We adhere to the business philosophy of "people-oriented, innovative development", regards quality and reputation as the lifeblood of the enterprise, emphasizes optimized management and technological innovation. The production base we cooperate with has advanced production technology, complete quality assurance system, leading testing methods and equipment. Since our establishment, we have provided high-quality products and professional services to domestic and foreign customers, winning the widespread trust of industry partners.

Voglibose API Introduction

Voglibose API can improve postprandial hyperglycemia in diabetes, which belongs to α - glucosidase inhibitor (a drug that can delay the absorption of carbohydrates in the intestine to achieve hypoglycemic effect). It mainly selectively inhibits sucrase and maltase, and its inhibitory activity against these two enzymes is much higher than that of acarbose. As it does not affect amylase, starch in food is converted into disaccharides in the small intestine, and very little starch enters the large intestine, resulting in fewer gastrointestinal reactions such as bloating and increased exhaust. The appearance is white powder. Voglibose API is prepared by reducing and aminating glucose lactone as a key intermediate. Our final product has high purity and good quality, and is the main choice for the production of formulations and scientific research.

Specifications

 Why Choose Us?

We strictly follow international quality standards, with product purity consistently above 99% and impurity control in accordance with ICH guidelines to ensure the safety and efficiency of your formulations. With large-scale production and vertically integrated supply chain, we offer competitive prices and stable supply, which can significantly reduce your production costs and out of stock risks. Our team is available 24 hours a day to promptly answer your inquiries and questions. Choose multi-channel transportation methods to ensure safe delivery of packages.

Main applications

The Voglibose API is mainly used for producing hypoglycemic drugs, and its core uses include:

• Treatment of type 2 diabetes: As an α - glucosidase inhibitor, it can delay the decomposition and absorption of carbohydrates in the intestine, thus reducing postprandial hyperglycemia.
• Combination therapy: often used in combination with other oral hypoglycemic drugs (such as Metformin) to improve blood sugar control effectiveness.
• Prevention of complications: by stabilizing the blood sugar level, reduce the risk of complications such as cardiovascular disease and kidney disease related to diabetes.
• Pharmaceutical preparation production: As an active ingredient, it is used to produce oral preparations such as Voglibose tablets and capsules.

if you need it , you can click here

Quality Control:

R&D Results:

Packaging and Transportation:

After-Sales Service:

Transaction Feedback:

Exhibition:

FAQ

Q1:What is the Mechanism of Action of Voglibose ？

A1:Mechanism of Action: Voglibose works in the small intestine by inhibiting alpha-glucosidase enzymes, which are responsible for breaking down complex carbohydrates (like starch) into simple sugars (glucose). This action delays the digestion and absorption of carbohydrates, thereby suppressing sharp increases in blood sugar levels after eating (postprandial hyperglycemia).

Q2:What is the difference between metformin and Voglibose?

A2:Voglibose delays glucose absorption by inhibiting the intestinal enzymes, which break complex sugars into simple sugars such as glucose. Metformin works by reducing the sugar production by cells in the liver and delaying sugar absorption from the intestines.

Q3:How secure is Voglibose?

A3:Voglibose is rarely absorbed as a prototype drug, with over 98% being metabolized in the intestine and excreted through feces, making it suitable for patients with mild to moderate liver dysfunction.

Contact Us

Are you intersted in our 99% Voglibose API. Please contact us via sales12@faithfulbio.com to get more information.